Building on novel experiments with amyloid fibrils — a type of protein aggregate associated with diseases like diabetes, Alzheimer’s, and Parkinson’s — a new set of experiments using serum albumins, the primary constituents of blood protein, was sent to the International Space Station (ISS) in March aboard SpaceX 27. This is the fourth time the experiment is being conducted on the ISS.